What is the recommended approach for converting an adult patient with hypertension or cardiovascular disease from nadolol (beta-blocker) to propranolol (beta-blocker)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Converting from Nadolol to Propranolol

Use a 1:1 dose ratio when converting from nadolol to propranolol, but divide the total daily propranolol dose into 2-4 administrations per day since propranolol requires multiple daily dosing while nadolol is given once daily. 1

Conversion Protocol

Step 1: Determine Equivalent Daily Dose

  • Convert nadolol to propranolol using a 1:1 ratio (e.g., nadolol 80 mg once daily = propranolol 80 mg total daily dose) 1
  • Research demonstrates that in 60% of patients, the effective total daily dose of propranolol and nadolol was identical, with an overall dose ratio of 1.17:1 (propranolol to nadolol) across all patients 1
  • However, individual dose titration is recommended because 40% of patients showed dosage variability when switching between these agents 1

Step 2: Divide Propranolol into Multiple Daily Doses

  • Administer propranolol in 2-4 divided doses per day rather than once daily, as propranolol has a shorter duration of action compared to nadolol's inherently long duration 2, 1
  • For immediate-release propranolol, the American College of Cardiology recommends 30-60 mg in divided doses with a maximum of 40-160 mg in divided or single dose with long-acting formulations 3
  • Example conversion: Nadolol 80 mg once daily → Propranolol 40 mg twice daily (or 20 mg four times daily for immediate-release)

Step 3: Verify No Contraindications Before Switching

Check for absolute contraindications that apply to both agents 3, 4:

  • AV block greater than first degree or SA node dysfunction without a pacemaker
  • Decompensated systolic heart failure or cardiogenic shock
  • Active asthma or reactive airway disease
  • Hypotension (systolic BP <100 mmHg with symptoms)

Step 4: Initiate Propranolol with Monitoring

  • Start propranolol the day after the last nadolol dose to avoid overlap, given nadolol's longer half-life 2
  • Monitor blood pressure and heart rate at each visit during the transition 3
  • Watch for bradycardia, hypotension, bronchospasm, and worsening heart failure as potential adverse effects common to both agents 3, 4

Step 5: Titrate Based on Clinical Response

  • Adjust propranolol dose every 1-2 weeks based on blood pressure and heart rate response 3
  • Target resting heart rate of 50-60 beats per minute unless limiting side effects occur 5
  • Maximum propranolol dose is 160 mg daily in divided doses for most indications, though higher doses may be used in specific circumstances 3, 4

Critical Differences Between Nadolol and Propranolol

Pharmacokinetic Distinctions

  • Nadolol is excreted entirely unchanged and not metabolized, while propranolol undergoes extensive hepatic metabolism 2
  • Nadolol has a longer duration of action (12.2-hour half-life) allowing once-daily dosing, whereas propranolol requires multiple daily doses 2, 6
  • Propranolol dosage may need reduction in patients with liver disease due to decreased drug clearance, while nadolol may be preferred in hepatic dysfunction 7

Shared Properties

  • Both are nonselective beta-blockers without cardioselectivity 3, 2
  • Both demonstrate comparable efficacy in controlling hypertension and angina 8, 1
  • Both have similar adverse effect profiles including hypotension, bradycardia, and bronchospasm 3, 4

Common Pitfalls to Avoid

  • Never abruptly discontinue nadolol before starting propranolol, as this can precipitate rebound hypertension, exacerbation of angina, myocardial infarction, and ventricular arrhythmias 7, 4
  • Do not assume a simple 1:1 conversion will work for all patients—40% showed dosage variability requiring individual titration 1
  • Avoid using propranolol in pre-excited atrial fibrillation, as it may precipitate very rapid ventricular rates 4
  • Do not combine propranolol with other AV nodal blocking agents (calcium channel blockers, digoxin) without careful monitoring, as profound bradycardia can develop 3
  • In diabetic patients, recognize that propranolol masks hypoglycemia symptoms and requires extreme caution 4

Special Populations

Patients with Liver Disease

  • Propranolol requires dose reduction in hepatic impairment due to decreased clearance 7
  • Avoid doses >160 mg/day total in decompensated cirrhosis, as higher doses are associated with worse survival outcomes 4

Patients with Alcohol Consumption

  • Start at lower propranolol doses (10-20 mg three times daily) in patients with known heavy alcohol consumption 7
  • Consider three-times-daily dosing to maintain more consistent blood levels 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Propranolol Dosing Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Metoprolol Treatment Protocol for Hypertension and Heart-Related Conditions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

Effect of nadolol in treatment of hypertension.

Journal of clinical pharmacology, 1979

Guideline

Propranolol Use in Patients Who Consume Alcohol: Precautions and Dosage Recommendations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Nadolol and propranolol in the treatment of hypertension: a double-blind comparison.

The Journal of international medical research, 1980

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.